|
Market Closed -
Euronext Paris
20:55:00 03/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0750 EUR | 0.00% |
|
+27.55% | -43.61% |
| 10-29 | IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 10-12 | ABL Texcell Diagnostics to Acquire French Biotech Company IntegraGen | MT |
Chart: Technical Analysis
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALINT | Real-time | |
Börse Stuttgart
| 7N8 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 0.104 | 0.361 | 0.237 |
| Spread/Res. | -27.88% | -79.22% | -68.35% |
| Spread/Supp. | +81.16% | +451.47% | +173.72% |
| Support | 0.0414 | 0.0136 | 0.0274 |
- Stock Market
- Stocks
- ALINT Stock
- Charts IntegraGen
Select your edition
All financial news and data tailored to specific country editions
